Viewing StudyNCT00410202



Ignite Creation Date: 2024-05-05 @ 5:14 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00410202
Status: COMPLETED
Last Update Posted: 2013-11-21
First Post: 2006-12-11

Brief Title: Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus
Sponsor:
Organization: Bristol-Myers Squibb

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 629
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: